Robeco Institutional Asset Management B.V. Sells 72,993 Shares of Aetna Inc. (AET)
Robeco Institutional Asset Management B.V. lowered its position in Aetna Inc. (NYSE:AET) by 20.6% during the third quarter, Holdings Channel reports. The firm owned 280,488 shares of the company’s stock after selling 72,993 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Aetna were worth $32,381,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. PGGM Investments boosted its stake in shares of Aetna by 54.7% in the second quarter. PGGM Investments now owns 794,893 shares of the company’s stock worth $97,080,000 after buying an additional 280,978 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Aetna by 4.1% in the second quarter. Nisa Investment Advisors LLC now owns 145,191 shares of the company’s stock worth $17,732,000 after buying an additional 5,750 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its stake in shares of Aetna by 24.9% in the third quarter. Oregon Public Employees Retirement Fund now owns 90,652 shares of the company’s stock worth $10,466,000 after buying an additional 18,063 shares in the last quarter. Retirement Systems of Alabama boosted its stake in shares of Aetna by 0.3% in the second quarter. Retirement Systems of Alabama now owns 178,739 shares of the company’s stock worth $21,829,000 after buying an additional 600 shares in the last quarter. Finally, Macquarie Group Ltd. boosted its position in Aetna by 5.8% in the second quarter. Macquarie Group Ltd. now owns 175,079 shares of the company’s stock valued at $21,382,000 after buying an additional 9,547 shares during the period. Hedge funds and other institutional investors own 88.28% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded down 0.51% during midday trading on Wednesday, reaching $131.36. The company’s stock had a trading volume of 459,602 shares. The firm has a market capitalization of $46.09 billion, a P/E ratio of 18.94 and a beta of 0.54. The stock has a 50-day moving average of $115.34 and a 200 day moving average of $116.60. Aetna Inc. has a 12-month low of $92.42 and a 12-month high of $132.36.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, October 27th. The company reported $2.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.02 by $0.05. Aetna had a net margin of 3.91% and a return on equity of 16.25%. The business earned $15.78 billion during the quarter, compared to the consensus estimate of $15.71 billion. During the same period in the previous year, the firm posted $1.90 earnings per share. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities research analysts predict that Aetna Inc. will post $8.02 EPS for the current fiscal year.
WARNING: This article was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another publication, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this article can be viewed at http://www.dailypolitical.com/2016/11/30/robeco-institutional-asset-management-b-v-sells-72993-shares-of-aetna-inc-aet.html.
Several equities analysts recently issued reports on the company. Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a research report on Tuesday, November 22nd. Sanford C. Bernstein cut Aetna from an “outperform” rating to a “market perform” rating and set a $132.00 price objective on the stock. in a research report on Monday, November 14th. Credit Suisse Group AG raised Aetna from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $120.00 to $125.00 in a research report on Friday, November 11th. Barclays PLC reaffirmed a “buy” rating and issued a $142.00 price objective on shares of Aetna in a research report on Monday, November 7th. Finally, Evercore ISI assumed coverage on Aetna in a research report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $132.14.
In other news, Director Jeffrey E. Garten sold 7,100 shares of Aetna stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.